SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ABTI Alpha-Beta Technology
ABTI 0.200+99,900.0%Jun 17 12:34 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (341)7/31/1997 2:33:00 PM
From: gaddis   of 572
 
Cacaito,

It would appear that our styles aren't so different after all. I was buying when ABTI was under pressure earlier this month and sold into this recent upsurge. I will wait until Phase 3 results are out to decide whether to re-establish a position. In discussing prior clinical results, I wasn't trying to make you an ABTI "believer" as Phase 2 results can really only determine whether further clinical testing is warranted. Nevertheless, I think it is important to learn how to "read" a clinical report and see if a particular company is upholding a rigorous scientific standard and see how subsequent clinical trials will be tailored. If ABTI can demonstrate strong data, I think we may see good price appreciation due to the wide-spread belief in the FDA's acceptance of the superior design of the Ph.3 clinical trial.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext